Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
Allison J. Greaney, Andrea N. Loes, Lauren E. Gentles, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 600
Open Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
Science (2022) Vol. 375, Iss. 6583, pp. 864-868
Open Access | Times Cited: 501
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 402
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Katharina Röltgen, Sandra C. A. Nielsen, Oscar Silva, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1025-1040.e14
Open Access | Times Cited: 374
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 339
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1621-1626
Open Access | Times Cited: 285
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Alice Cho, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 517-522
Open Access | Times Cited: 274
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
Science (2022) Vol. 378, Iss. 6620, pp. 619-627
Open Access | Times Cited: 193
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
Rachna T. Shroff, Pavani Chalasani, Ran Wei, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 2002-2011
Open Access | Times Cited: 192
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 174
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Alexandra C. Walls, Marcos C. Miranda, Alexandra Schäfer, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5432-5447.e16
Open Access | Times Cited: 161
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Xaquín Castro Dopico, Sebastian Ols, Karin Loré, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 32-50
Open Access | Times Cited: 145
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Young‐Jun Park, Anna De Marco, Tyler N. Starr, et al.
Science (2022) Vol. 375, Iss. 6579, pp. 449-454
Open Access | Times Cited: 141
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Katlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1008-1024.e15
Open Access | Times Cited: 138
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
Harry Kleanthous, Judith M. Silverman, Karen W. Makar, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 136
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-Pan Zhou, Ge Song, Hejun Liu, et al.
Immunity (2023) Vol. 56, Iss. 3, pp. 669-686.e7
Open Access | Times Cited: 111
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
Philip L. Tzou, Kaiming Tao, Sergei L. Kosakovsky Pond, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0261045-e0261045
Open Access | Times Cited: 93
Photoelectrochemical biosensing platforms for tumor marker detection
Jiaju Shi, Zichao Chen, Chunqin Zhao, et al.
Coordination Chemistry Reviews (2022) Vol. 469, pp. 214675-214675
Closed Access | Times Cited: 76
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Katherine Nabel Smith, Sarah A. Clark, Sundaresh Shankar, et al.
Science (2022) Vol. 375, Iss. 6578
Open Access | Times Cited: 75
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
John E. Bowen, Young‐Jun Park, Cameron Stewart, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 70
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Allison J. Greaney, Tyler N. Starr, Rachel Eguia, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010248-e1010248
Open Access | Times Cited: 67
Learning from prepandemic data to forecast viral escape
Nicole N. Thadani, Sarah F. Gurev, Pascal Notin, et al.
Nature (2023) Vol. 622, Iss. 7984, pp. 818-825
Open Access | Times Cited: 66
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans
M. Alejandra Tortorici, Amin Addetia, Albert J. Seo, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 904-911.e4
Open Access | Times Cited: 51
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top